Example: Heart Attack

Search clinical trials for: Hydroquinone

Total 27 results

NCT04345094

Completed

Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging

Conditions: Photoaging
NCT04312152

Enrolling by invitation

Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.

Conditions: Autism Spectrum Disorder; Phelan-McDermid Syndrome
NCT04197115

Recruiting

Vitamin C, Thiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone in Sepsis

Conditions: Sepsis; Septic Shock
NCT04109924

Recruiting

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Conditions: Advanced Colorectal Carcinoma; Metastatic Colon Adenocarcinoma; Metastatic Rectal Adenocarcinoma; Recurrent Colon Adenocarcinoma; Recurrent Colorectal Adenocarcinoma; Recurrent Rectal Adenocarcinoma; Stage III Colon Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8; Stage IIIA Colon Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIB Rectal Cancer AJCC v8; Stage IIIC Colon Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colon Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVA Rectal Cancer AJCC v8; Stage IVB Colon Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVB Rectal Cancer AJCC v8; Stage IVC Colon Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Stage IVC Rectal Cancer AJCC v8; Unresectable Colon Adenocarcinoma; Unresectable Colorectal Carcinoma; Unresectable Rectal Adenocarcinoma
NCT03982849

Completed

Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma

Conditions: Melasma
NCT03751163

Completed

Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma

Conditions: Melasma
NCT03585179

Unknown status

Oral and Topical Tranexamic Acid for the Treatment of Melasma

Conditions: Melasma; Chloasma; Melanosis
NCT03049059

Completed

A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma

Conditions: Picoseconds Laser; Melasma
NCT03040089

Completed

Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm

Conditions: Melasma
NCT02977507

Completed

Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma

Conditions: Melasma
NCT02138539

Completed

Evaluation of an Herbal-Based De-Pigmenting System

Conditions: Melasma; Hyperpigmentation
NCT02095990

Completed

Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

Conditions: Facial Melasma
NCT01990729

Completed

Efficacy and Safety of ARTRA (Glucosamine Plus Chondroitin Sulfate Combination) in Treatment of Chronic Low Back Pain

Conditions: Low Back Pain
NCT01661556

Unknown status

Clinical Trial of Hydroquinone Versus Miconazol in Melasma

Conditions: Melasma
NCT01085279

Completed

Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)

Conditions: Pigmentation Disorder
NCT01083498

Completed

Fractional Laser as Treatment Option for Various Pigment Disorders

Conditions: Pigmentation Disorder
NCT01001624

Completed

Melanil in the Treatment of Melasma

Conditions: Melasma
NCT00975312

Completed

Solar Lentigines Treatment With the Triple Combination Cream

Conditions: Lentigo
NCT00927771

Unknown status

Azelaic Acid Versus Hydroquinone in Melasma

Conditions: Melanosis
NCT00863278

Terminated

Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser

Conditions: Melanosis
NCT00755664

Completed

Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly

Conditions: Hyperhomocysteinemia
NCT00717652

Suspended

Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma

Conditions: Melasma
NCT00669071

Terminated

Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

Conditions: Melasma
NCT00628017

Completed

Preliminary Study of Fish Oil and Dementia

Conditions: Alzheimer's Disease; Mild Cognitive Impairment
NCT00616239

Completed

Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women

Conditions: Melasma
NCT00472966

Completed

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Conditions: Melasma
NCT00469183

Completed

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Conditions: Melasma

Search clinical trials for: Hydroquinone

Recent CRA jobs

Clinical Manager - Home-Based - West/Midwest

Scientist - Large Molecule HPLC ( SEC , IEX , RP )

Sr. Lab Tech/Scient Aff Spec

Sr Project Manager - Peri and Post Approval - Interventional Hematolgy / Oncology Team

Sr Project Manager - Gene Therapy / Rare Diseases

Manager Commercial Dev

CRA - Study Start Up

Associate Scientist / Scientist - Instrument Technician , GMP

Senior Regulatory Affairs Associate (MAA)

Senior Manager, IT Service Operations